These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16302101)

  • 1. Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice.
    Pires JG; Bonikovski V; Futuro-Neto HA
    Braz J Med Biol Res; 2005 Dec; 38(12):1867-72. PubMed ID: 16302101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of interaction between fluoxetine and isosorbide dinitrate on neuroleptic-induced catalepsy in mice.
    Pires JG; Fonseca FC; Woelffel AB; Futuro-Neto HA
    Braz J Med Biol Res; 1998 Mar; 31(3):417-20. PubMed ID: 9698792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat.
    Sokolowski JD; Seiden LS
    Psychopharmacology (Berl); 1999 Nov; 147(2):153-61. PubMed ID: 10591882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice.
    Amada N; Hirose T; Suzuki M; Kakumoto Y; Futamura T; Maeda K; Kikuchi T
    Neuropsychopharmacol Rep; 2023 Mar; 43(1):132-136. PubMed ID: 36649966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related differences in the effects of nitric oxide donors on neuroleptic-induced catalepsy in mice.
    Pires JG; Costa PG; Saraiva FP; Bonikovski V; Futuro Neto HA
    Braz J Med Biol Res; 2003 Feb; 36(2):239-45. PubMed ID: 12563527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sertraline on experimental mouse models of psychosis.
    Bilge U; Erol K
    Neurosciences (Riyadh); 2012 Jan; 17(1):32-8. PubMed ID: 22246007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
    Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S
    Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers.
    Liston HL; DeVane CL; Boulton DW; Risch SC; Markowitz JS; Goldman J
    J Clin Psychopharmacol; 2002 Apr; 22(2):169-73. PubMed ID: 11910262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity.
    Tiradentes RV; Pires JG; Silva NF; Ramage AG; Santuzzi CH; Futuro Neto HA
    Braz J Med Biol Res; 2014 Jul; 47(7):554-9. PubMed ID: 25003632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.
    Isaac R; Boura-Halfon S; Gurevitch D; Shainskaya A; Levkovitz Y; Zick Y
    J Biol Chem; 2013 Feb; 288(8):5682-93. PubMed ID: 23275337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolic effects of fluoxetine, fluvoxamine, paroxetine and sertraline in the conscious rat.
    Freo U; Merico A; Ermani M; Ori C
    Neurosci Lett; 2008 May; 436(2):148-52. PubMed ID: 18387742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice.
    Da-Rocha MA; Puech AJ; Thiébot MH
    J Psychopharmacol; 1997; 11(3):211-8. PubMed ID: 9305412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
    Preskorn SH; Shah R; Neff M; Golbeck AL; Choi J
    J Psychiatr Pract; 2007 Jan; 13(1):5-12. PubMed ID: 17242587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.